Although some patients have hyperinsulinemia or insulin resistance, they are treated with insulin or insulin analogs when treatment with adequate doses of other available anti-diabetic drugs does not lead to the target optimized blood glucose control. This evidence concerns the gene INS and hyperinsulinism.